My POV: Veeva or Salesforce? Why You Are the Real Winner
The Opportunity
There’s been a big industry conversation since last year: Which will come out on top—Veeva or Salesforce? The truth is, the winner should be you (i.e., the industry).
We’re in a once-in-a-decade scenario where these core infrastructure vendors want your business more than ever. In their quest to compete, they should be offering you the very best deal and the most compelling roadmap. So, don’t rush. Think about the big picture, negotiate, and position yourself to benefit from their competition.
Don’t Start with Features—Start with Vision
Instead of comparing features and roadmaps right away, consider your long-term enterprise vision:
Avoid “fear of missing out.” Some companies jumped on the Veeva train without a second thought—it might have worked for them, but that doesn’t automatically mean it’s right for you.
My Experience
I’ve spent time at Slalom, a long-time Salesforce partner, and I’ve also worked for Veeva. Here’s how I see the key differences:
Despite these differences, both are best-in-class in their own areas. IQVIA’s partnership with Salesforce and the influx of new talent and funding within Life Sciences also factor in. But remember: both vendors sell a platform and want to lock you into their ecosystem, so whichever you choose think about the platform you are buying.
领英推荐
The Business Landscape Is Changing
We’re at the dawn of a GenAI/AI revolution that could fundamentally alter how we view SaaS. Just as laptops eclipsed PCs and SaaS overtook on-premise, we may soon see Agentic Business Software emerge—where chat interfaces, voice, and contextual interactions dramatically boost productivity. This could mean:
So, when planning for Salesforce or Veeva, don’t just solve yesterday’s problems. Consider tomorrow’s—and watch out for new players who might offer leaner, AI-driven solutions at competitive prices. If you’re a newer biotech company just starting out, for instance, a custom CRM could actually be enough.
Timing Is Everything
Given all this change, take your time. The window of opportunity is wide open, and you’re in the driver’s seat, evaluate what’s your organization window of opportunity is and evaluate all options. Veeva and Salesforce is the box we have been familiar with, we need to step out of the box and see what’s the right choice.
In five years, the Life Sciences CRM landscape will look different—more diverse, more competitive, and driven by AI. Both Salesforce and Veeva will have to adapt, but so will you.
Final Thoughts
If you’re feeling overwhelmed, remember: You hold the power. Take advantage of this competitive moment, think strategically about where your organization is headed, and evaluate how any CRM solution—Salesforce, Veeva, or otherwise—maps to that future.
Enjoy the ride!
?
Head of NorCal GTM & Global Life Sciences at Slalom
1 周Love it! Sounds like you'll have a lot to say at the CRM summit next week!
Salesforce Architect | Ex-Microsoft & Salesforce | US Citizen | 10+ Years in Salesforce | Proven Scalable Solutions, Complex Integrations, Financial Services Cloud, Data Migration, and Enterprise Architecture
3 周Great breakdown! Veeva’s industry depth gives it an edge, but Salesforce’s AI-driven push is hard to ignore. The real question is whether Veeva can stay dominant without opening up, while Salesforce bets on flexibility and scale. With AI shifting priorities, do you see the industry leaning toward specialized solutions or all-in-one platforms?
Regulatory Advertising & Promotion | Global change management | integration Management | Regulatory Intelligence | Veeva Implementation and Training | MLR
3 周Very thoughtful, Lefteris. With the disruption caused by AI and platforms like Salesforce and IQVIA in the life sciences sector, the traditional model of investing in a single platform with a suite of products will soon become obsolete. New, seamless integration capabilities will dismantle this approach. You are right that industry is the winner.